Cargando…

Impact of bloodstream infections caused by carbapenem-resistant Gram-negative pathogens on ICU costs, mortality and length of stay

BACKGROUND: The aim of this study was to estimate the impact of bloodstream infections (BSIs) caused by carbapenem-resistant Gram-negative (CRGN) pathogens on hospital costs, mortality and length of stay (LOS). METHODS: All patients hospitalized for ≥3 days in the Intensive Care Unit (ICU) of a tert...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kousouli, E., Zarkotou, O., Polimeri, K., Themeli-Digalaki, K., Pournaras, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335918/ https://www.ncbi.nlm.nih.gov/pubmed/34368681 http://dx.doi.org/10.1016/j.infpip.2019.100020

Ejemplares similares

Linezolid Dependence in Staphylococcus epidermidis Bloodstream Isolates
por: Pournaras, Spyros, et al.
Publicado: (2013)

Bloodstream Infections in a COVID-19 Non-ICU Department: Microbial Epidemiology, Resistance Profiles and Comparative Analysis of Risk Factors and Patients’ Outcome
por: Giannitsioti, Efthymia, et al.
Publicado: (2022)

2076. Intestinal colonization with multidrug-resistant organisms, horizontal transmission and risk for bloodstream infection
por: Karakosta, Polyxeni, et al.
Publicado: (2023)

Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter Study
por: McCann, Eilish, et al.
Publicado: (2018)

Isolated microorganisms in plastic biliary stents placed for benign and malignant diseases
por: Basioukas, Paris, et al.
Publicado: (2014)

2479. Impact of the COVID-19 pandemic on the hospital acquisition of multidrug-resistant organism in two Greek hospitals
por: Karakosta, Polyxeni, et al.
Publicado: (2023)

Bloodstream infections in NNICU: Blight on ICU stay
por: Mehndiratta, Man Mohan, et al.
Publicado: (2016)

1191. Prevalence and Microbiology of Carbapenem Resistance Among Six Gram-Negative Pathogens in Bloodstream Infections in US Hospitals, 2010–2015
por: Lodise, Thomas P, et al.
Publicado: (2018)

Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens
por: Lee, Chang-Seop, et al.
Publicado: (2014)

Prevalence of bloodstream infection pathogens in hemato-oncological patients and predictors of carbapenem-resistant gram-negative bacterial infections during febrile neutropenia
por: Schonardie, Ana Paula, et al.
Publicado: (2023)

An institutional perspective on the impact of recent antibiotic exposure on length of stay and hospital costs for patients with gram-negative sepsis
por: Micek, Scott, et al.
Publicado: (2012)

Analysis of ICU physician predictions for ICU length of stay
por: N Junior, Antonio Paulo, et al.
Publicado: (2015)

Emergence of carbapenem resistance in Gram-negative nosocomial bloodstream infections among critically ill children? A single-center experience
por: Sasidaran, K, et al.
Publicado: (2012)

2163. Risk Factors for Carbapenem-Resistant Gram-Negative Bloodstream Infections (BSI) in U.S. Hospitals (2010–2015)
por: Cai, Bin, et al.
Publicado: (2018)

Length of hospital stay prior to ICU admission and outcome
por: Simpson, K, et al.
Publicado: (2011)

Clinical Efficacy and Cost-Effectiveness of β-Lactam/β-Lactamase Inhibitor Combinations and Carbapenems in Liver Cirrhosis Patients with Gram-Negative Bacteria Bloodstream Infection
por: Dong, Yuzhu, et al.
Publicado: (2020)

Ceftazidime-Avibactam for Carbapenem-Resistant Gram-Negative Bacteria Infections: A Real-World Experience in the ICU
por: Yu, Jiaxin, et al.
Publicado: (2023)

Pre-ICU length of hospital stay is a predictor of hospital but not ICU mortality
por: Flavin, K, et al.
Publicado: (2015)

Excess Length of Acute Inpatient Stay Attributable to Acquisition of Hospital-Onset Gram-Negative Bloodstream Infection with and without Antibiotic Resistance: A Multistate Model Analysis
por: Suzuki, Hiroyuki, et al.
Publicado: (2020)

216. Association Between Days to Initiate Appropriate Therapy and Hospital Length of Stay Among Adult Hospitalized Patients With Gram-negative Bloodstream Infections (GN-BSI)
por: Lodise, Thomas, et al.
Publicado: (2019)

Costs and Extra Length of Stay because of Neonatal Bloodstream Infection at a Teaching Hospital in Ghana
por: Fenny, Ama Pokuaa, et al.
Publicado: (2020)

Procalcitonin Levels in Gram-Positive, Gram-Negative, and Fungal Bloodstream Infections
por: Leli, Christian, et al.
Publicado: (2015)

Antibiotic synergy testing for multidrug-resistant Gram-negative pathogens in a Greek ICU
por: Douka, E, et al.
Publicado: (2015)

Efficacy and In Vitro Activity of Novel Antibiotics for Infections With Carbapenem-Resistant Gram-Negative Pathogens
por: Cruz-López, Flora, et al.
Publicado: (2022)

The prevalence of Carbapenem Resistance Gram negative pathogens in a Tertiary Teaching Hospital in Jordan
por: Hammour, Khawla Abu, et al.
Publicado: (2023)

Gastrointestinal Carriage of Vancomycin-Resistant Enterococci and Carbapenem-Resistant Gram-Negative Bacteria in an Endemic Setting: Prevalence, Risk Factors, and Outcomes
por: Vasilakopoulou, Alexandra, et al.
Publicado: (2020)

Persistent bacteremia predicts poor outcomes among neutropenic patients with carbapenem-resistant gram-negative bloodstream infections receiving appropriate therapy
por: Sathya Kumar, Abi Manesh, et al.
Publicado: (2023)

Daily multidisciplinary rounds reduce ICU length of stay
por: Pacheco, ES, et al.
Publicado: (2011)

Influence of Appropriate Empirical Antibiotic Treatment on the Prognosis of ICU Patients with HAP Caused by Carbapenem-Resistant Gram-Negative Bacteria
por: Zhang, Xiaoling, et al.
Publicado: (2023)

Factors Affecting ICU Stay and Length of Stay in the ICU in Patients with HELLP Syndrome in a Tertiary Referral Hospital
por: Ağaçayak, Elif, et al.
Publicado: (2022)

The length of stay and the hospital cost for ICU patients with resistant bacterial infections: a pilot study
por: Priyendu, Asim, et al.
Publicado: (2014)

Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
por: Nordmann, Patrice, et al.
Publicado: (2019)

Global Threat of Carbapenem-Resistant Gram-Negative Bacteria
por: Jean, Shio-Shin, et al.
Publicado: (2022)

The increased risks of death and extra lengths of hospital and ICU stay from hospital-acquired bloodstream infections: a case–control study
por: Barnett, Adrian G, et al.
Publicado: (2013)

Antibiogram and Genetic Characterization of Carbapenem-Resistant Gram-Negative Pathogens Incriminated in Healthcare-Associated Infections
por: Makharita, Rabab R, et al.
Publicado: (2020)

Extended-Spectrum Beta-Lactamase and Carbapenem-Resistant Gram-Negative Pathogens in Makkah, Saudi Arabia
por: Kabrah, Ahmed
Publicado: (2022)

2302. Bloodstream Infections Due to Carbapenem-Resistant Gram-Negative Bacteria in Pediatric Intensive Care Unit (PICU): Risk Factors and Outcomes
por: Darda, Violetta-Magdalini, et al.
Publicado: (2018)

The Threat of Carbapenem-Resistant Gram-Negative Bacteria in Patients with Hematological Malignancies: Unignorable Respiratory Non-Fermentative Bacteria-Derived Bloodstream Infections
por: Lu, Linli, et al.
Publicado: (2022)

Dalbavancin Efficacy and Impact on Hospital Length-of-Stay and Treatment Costs in Different Gram-Positive Bacterial Infections
por: Poliseno, Mariacristina, et al.
Publicado: (2021)

Comparison of Risk Factors and Outcomes in Carbapenem-Resistant and Carbapenem-Susceptible Gram-Negative Bacteremia
por: Cetin, Sinan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_67jnktvap8d55jjbu87evh5dak